Promise of Tau | Oligomerix

Careers
Contact Us
Media Kit

Search for:

Home
Company Overview
Scientific Background
Therapeutic Focus
Pipeline & Intellectual Property
News

Refer

Refer Print

© 2021 Oligomerix, Inc.
Website by Axxiem

Follow Us:

Company Overview
History & Mission Statement
Board of Directors
Management Team
Scientific Advisory Board
Partners & Investors

Scientific Background
Tauopathies
Formation of Tau Oligomers in Disease
Toxicity and Impairment of Memory Formation
Media Kit

Therapeutic Focus
Inhibitors of Tau Oligomer Formation
Inhibitors of Tau Oligomer Proteolytic Activity

Pipeline
Intellectual Property

Press Releases
Media Coverage

Scientific Publications